ABOS: Acumen Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 191.65
Enterprise Value ($M) 154.67
Book Value ($M) 266.97
Book Value / Share 4.44
Price / Book 0.72
NCAV ($M) 203.46
NCAV / Share 3.39
Price / NCAV 0.94

Profitability (mra)
Return on Invested Capital (ROIC) -0.18
Return on Assets (ROA) -0.28
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 19.01
Current Ratio 19.01

Balance Sheet (mrq) ($M)
Current Assets 246.62
Assets 310.12
Liabilities 43.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -61.14
Net Income -52.37

Cash Flow Statement (mra) ($M)
Cash From Operations -43.06
Cash from Investing -171.67
Cash from Financing 151.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Deep Track Capital, LP 0.00 -100.00
02-06 13G Franklin Resources Inc 5.80
01-24 13G/A Murray James B Jr 4.60 3.87
07-25 13D/A Ra Capital Management, L.p. 25.90 53.27

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 18,343 134,449 13.64
2024-04-25 43,505 43,153 100.82
2024-04-24 23,028 44,364 51.91
2024-04-23 32,391 70,894 45.69

(click for more detail)

Similar Companies
ABCL – AbCellera Biologics Inc. ABUS – Arbutus Biopharma Corporation
ACAD – ACADIA Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io